Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer

被引：0
|
作者：
Macek, P.
Stricker, P.
Stevens, M.
Jagavkar, R.
Chalasani, V.
Haynes, A. M.
Matthews, J.
Brenner, P.
Golovsky, D.
Kooner, R.
O'Neill, G.
机构：
[1] Gen Univ Hosp, Prague, Czech Republic
[2] Garvan Inst Med Res, Sydney, NSW, Australia
来源：
BJU INTERNATIONAL | 2006年 / 97卷
关键词：
D O I：
10.1111/j.1464-410X.2006.06085_12.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] Dose escalation with HDR brachytherapy in high risk prostate cancer: comparison of two consecutive protocols
    Olarte Garcia, A.
    Valtuena, G.
    Cambeiro, M.
    Moreno, M.
    Aristu, J. J.
    Arbea, L.
    Ramos, L.
    Barbes, B.
    Azcona, D.
    Martinez-Monge, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S157 - S158
  • [42] Preliminary analysis of HDR prostate brachytherapy in the management of patients with localized prostate cancer
    Springer, C
    Skeates, L
    Copps, C
    McKenzie, A
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S27 - S28
  • [43] HDR Brachytherapy in the Management of High-Risk Prostate Cancer (Vol 2012, 980841, 2012)
    Masson, Susan
    Persad, Raj
    Bahl, Amit
    ADVANCES IN UROLOGY, 2016, 2016
  • [44] Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group
    Ka, Kanta
    Schiappa, Renaud
    Terlizzi, Mario
    Mallet, Frederic
    Martin, Etienne
    Chand, Marie -Eve
    Demogeot, Nicolas
    Peiffert, Didier
    Pommier, Pascal
    Quivrin, Magali
    Kissel, Manon
    Pasquier, Corentin
    Khalifa, Jonathan
    Bossi, Alberto
    Hannoun-Levi, Jean -Michel
    Blanchard, Pierre
    RADIOTHERAPY AND ONCOLOGY, 2023, 180
  • [45] Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer
    Crook, Juanita
    BRACHYTHERAPY, 2015, 14 (02) : 142 - 147
  • [46] Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapy
    Anna Thi Huyen Tran
    Mandall, Paula
    Swindell, Ric
    Hoskin, P. J.
    Bottomley, David Martin
    Logue, John Paul
    Wylie, James Pinson
    RADIOTHERAPY AND ONCOLOGY, 2013, 109 (02) : 235 - 240
  • [47] Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy
    Markovic, Emily Schlussel
    Buckstein, Michael
    Stone, Nelson N.
    Stock, Richard G.
    BJU INTERNATIONAL, 2018, 121 (05) : 774 - 780
  • [48] Risk analysis of HDR prostate brachytherapy procedures
    Santos, T.
    Alves, C.
    Miranda, C.
    Lopes, M. D. C.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1957 - S1958
  • [49] Trimodal therapy outcomes for intermediate risk Prostate Cancer Patients
    Monaghan, O.
    O'Sullivan, S.
    Small, C.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S279 - S279
  • [50] Outcomes for Patients With Intermediate-, High-, and Very-High-Risk Prostate Cancer Treated With a Combination of External Beam Radiation Therapy and Brachytherapy
    Kiffel, J.
    Kiffel, E. R.
    Mandel, A. L.
    Stone, N. N.
    Stock, R. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E199 - E200
12345